Further work on the role of individual immune indicators vs. a composite biomarker tool using bFGF, eotaxin, and IL-5 simultaneously in blood samples from EoE vs. GERD vs. HC could be studied. This evidence concerns the gene CCL11 and eosinophilic esophagitis.